Comparison of two anesthesia methods in children undergoing fiberoptic bronchoscopy through laryngeal mask

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026098

Enrollment

Unknown

Registered

2019-09-21

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric pneumonia

Interventions

Remifentanil:Remifentanil 0.3-0.5µg/kg.min

Sevoflurane:4%-6% sevoflurane

Eligibility

Sex/Gender

All

Age

1 Years to 3 Years

Inclusion criteria

Inclusion criteria: 1. Volunteer to participate in the study and sign the informed consent; 2. Age is less than 3 years old; 3. Plan to participate in FOB; 4. ASA I-II?.

Exclusion criteria

Exclusion criteria: 1. BMI28; 2. Hemoptysis; 3. Complete the treatment or remove the foreign body through FOB examination; 4. Have disease of nervous system or endocrine system; 5. Family history of malignant high fever; 6. Long-term medication history.

Design outcomes

Primary

Measure	Time frame
PACU residence time;	—

Secondary

Measure	Time frame
whether restlessness occurred in the wake process;	—

Countries

China

Contacts

Public ContactRuiFeng Zeng

Wenzhou Medical University

ruifengzeng@163.com+86 13857734776

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026